NCT03123471 A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp Status COMPLETED Phase PHASE3
NCT03099083 Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab Status COMPLETED Phase N/A
NCT03097003 A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium Status COMPLETED Phase N/A
NCT03090100 A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis Status COMPLETED Phase PHASE3
NCT03073213 A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris Status COMPLETED Phase PHASE1
NCT03069144 Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis Status COMPLETED Phase PHASE1/PHASE2
NCT03062618 A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT03058744 Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT03051347 Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments Status COMPLETED Phase NA
NCT03047395 A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) Status COMPLETED Phase PHASE3
NCT03022617 A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis Status COMPLETED Phase PHASE4
NCT03022045 A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis Status COMPLETED Phase PHASE3